IL22 and colitis: Although much more extensive works still need to fully dissect out the mechanism that determines the beneficial versus deleterious effect of IL-22 on colitis and that stimulates the tumorigenesis pathway, IL-22 activation would be considered to be a promising therapeutic measures for IBD.